These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16085545)

  • 41. High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.
    Low M; Lee D; Coutsouvelis J; Patil S; Opat S; Walker P; Schwarer A; Salem H; Avery S; Spencer A; Wei A
    Intern Med J; 2013 Mar; 43(3):294-7. PubMed ID: 22757980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
    Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
    Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
    Stone RM; Berg DT; George SL; Dodge RK; Paciucci PA; Schulman P; Lee EJ; Moore JO; Powell BL; Schiffer CA
    N Engl J Med; 1995 Jun; 332(25):1671-7. PubMed ID: 7760868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of cytokines on the toxicity of cytostatic drugs to normal bone marrow cells in vitro.
    Sundman-Engberg B; Paul C; Tidefelt U
    Cancer Chemother Pharmacol; 1998; 42(3):255-60. PubMed ID: 9685063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in granulocyte-macrophage colony formation in relation to chemotherapy and clinical progress in acute myeloblastic leukaemia patients.
    Miyao S; Tamura J; Sakuraya M; Murakami H; Naruse T
    J Int Med Res; 1998 Dec; 26(6):271-80. PubMed ID: 10399109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.
    Song LX; Xu L; Li X; Chang CK; Zhang Y; Wu LY; He Q; Zhang QX; Li X
    Ann Hematol; 2012 Dec; 91(12):1879-86. PubMed ID: 22895556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the drug sensitivity of acute nonlymphocytic leukaemia using the in vitro clonogenic assay.
    Preisler HD; Azarnia N
    Br J Haematol; 1984 Dec; 58(4):633-40. PubMed ID: 6518136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitivity of myeloid progenitor cells in healthy subjects and patients with chronic myeloid leukemia to chemotherapeutic agents.
    Spiro TE; Mattelaer MA; Efira A; Stryckmans P
    J Natl Cancer Inst; 1981 Jun; 66(6):1053-9. PubMed ID: 6941040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro culture of clonogenic leukaemic cells in acute myeloid leukaemia: growth pattern and drug sensitivity.
    Marie JP; Zittoun R; Thevenin D; Mathieu M; Viguie F
    Br J Haematol; 1983 Nov; 55(3):427-37. PubMed ID: 6580036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemia.
    Ross DD
    Curr Opin Oncol; 1991 Feb; 3(1):21-9. PubMed ID: 1675126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Leukemic clonogenic assay and drug sensitivity test of homoharringtonine and cytarabine in acute myeloid leukemia].
    Ma FS; Gao RL; Jin JM
    Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):737-40, 769. PubMed ID: 2636093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin.
    Schölzel C; van Putten W; Löwenberg B
    Leuk Res; 1986; 10(12):1455-9. PubMed ID: 3467144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A non-clonogenic assay for the determination of the sensitivity of leukemic cells to chemotherapeutic agents.
    Epstein J; Preisler HD
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1569-74. PubMed ID: 6605856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenosine diphosphate ribosyl transferase in marrow cells of patients with acute myeloid leukemia is related to differentiation and drug sensitivity.
    Pero RW; Olofsson T; Gustavsson A; Kjellén E
    Carcinogenesis; 1985 Jul; 6(7):1055-8. PubMed ID: 2990754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoliposomes in Acute Myeloid Leukaemia Therapy: An Overview of Possible Targets and Obstacles.
    Singh A; Myklebust NN; Furevik SMV; Haugse R; Herfindal L
    Curr Med Chem; 2019; 26(28):5278-5292. PubMed ID: 31099318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An in vitro model for acute myelogenous leukemia chemotherapy.
    Koeffler HP; Yen J; Lowe L
    Cancer; 1981 Nov; 48(9):1958-63. PubMed ID: 6945901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of response to chemotherapy in acute myelocytic leukemia.
    Preisler HD
    Blood; 1980 Sep; 56(3):361-7. PubMed ID: 6931620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells.
    Park CH; Amare M; Savin MA; Goodwin JW; Newcomb MM; Hoogstraten B
    Blood; 1980 Apr; 55(4):595-601. PubMed ID: 7357086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia.
    Smyth JF; Robins AB; Leese CL
    Eur J Cancer (1965); 1976 Jul; 12(7):567-73. PubMed ID: 1066282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.